Overview : On 29 March 2026, Dr Jitendra Singh , Union Minister of State (Independent Charge) for Ministry of Science & Technology and other portfolios, released a comprehensive cardiology textbook titled “Advances in Obesity and Lipid Management in CVD”. The book underscores that central obesity is a more potent risk factor than overall obesity, especially in India where many lean‑looking individuals harbour substantial visceral fat . Key Developments Launch of the textbook comprising 23 sections and 172 chapters, authored by over 300 national and international experts. Emphasis on early detection of metabolic syndrome linked to abdominal obesity. Inclusion of emerging therapies such as GLP‑1 receptor agonists , PCSK9 inhibitors , bempedoic acid, ezetimibe, and gene‑based interventions. Shift from conventional risk‑factor management to precision prevention aided by digital health and AI‑enabled clinical decision systems . Alignment with Prime Minister Narendra Modi’s call for “Obesity‑Free Bharat” through public awareness, reduced oil consumption, and lifestyle modification. Important Facts The textbook is edited by renowned cardiologist Dr H.K. Chopra and features contributions from leading experts such as Dr Viveka Kumar , Dr Praveen Chandra , and Dr J.P.S. Sawhney . It highlights that abdominal obesity, even in non‑obese individuals, predisposes to diabetes, hypertension, fatty liver disease, dyslipidaemia and premature cardiovascular events. Projections suggest a sharp rise in obesity prevalence in India by 2050, amplifying the economic and health burden. UPSC Relevance Understanding the distinction between central obesity and overall obesity is vital for GS‑4 (Health, Social Issues) and for answering questions on non‑communicable disease (NCD) burden. The role of the Ministry of Science & Technology illustrates inter‑ministerial coordination, a topic in GS‑1 (Governance) and GS‑3 (Science & Technology). Emerging pharmacological options like GLP‑1 receptor agonists and PCSK9 inhibitors are frequently asked in questions on health technology and drug innovation. Way Forward Strengthen nationwide screening for visceral fat using waist‑circumference and imaging where feasible. Promote sustained lifestyle discipline – balanced diet, regular physical activity, adequate sleep – as advocated by the minister. Integrate digital health platforms for risk assessment, tele‑consultations, and adherence monitoring. Encourage research and capacity building in precision prevention to shift from treatment‑centric to prevention‑centric models. Leverage inter‑ministerial coordination (Science & Technology, Health, Finance) to fund public‑awareness campaigns and subsidise newer lipid‑lowering agents for high‑risk groups.